P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.91 CNY 0.16% Market Closed
Market Cap: 4.4B CNY

Pulike Biological Engineering Inc
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pulike Biological Engineering Inc
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Other Receivables
ÂĄ73.2m
CAGR 3-Years
48%
CAGR 5-Years
53%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Receivables
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Receivables
ÂĄ144.9m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Receivables
ÂĄ1.5B
CAGR 3-Years
-21%
CAGR 5-Years
-1%
CAGR 10-Years
2%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Other Receivables
ÂĄ134.3m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Receivables
ÂĄ74.5m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Pulike Biological Engineering Inc
Glance View

Market Cap
4.4B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
18.02 CNY
Undervaluation 28%
Intrinsic Value
Price
P

See Also

What is Pulike Biological Engineering Inc's Other Receivables?
Other Receivables
73.2m CNY

Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Other Receivables amounts to 73.2m CNY.

What is Pulike Biological Engineering Inc's Other Receivables growth rate?
Other Receivables CAGR 5Y
53%

Over the last year, the Other Receivables growth was 45%. The average annual Other Receivables growth rates for Pulike Biological Engineering Inc have been 48% over the past three years , 53% over the past five years .

Back to Top